| Computer-based training for the treatment of partial blindness E Kasten, S Wüst, W Behrens-Baumann, BA Sabel Nature medicine 4 (9), 1083-1087, 1998 | 447 | 1998 |
| Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine. CK Vorwerk, SA Lipton, D Zurakowski, BT Hyman, BA Sabel, EB Dreyer Investigative ophthalmology & visual science 37 (8), 1618-1624, 1996 | 447 | 1996 |
| Nanoparticle technology for delivery of drugs across the blood–brain barrier U Schroeder, P Sommerfeld, S Ulrich, BA Sabel Journal of pharmaceutical sciences 87 (11), 1305-1307, 1998 | 427 | 1998 |
| Controlled drug delivery system for treatment of neural disorders BA Sabel, A Freese, WM Saltzman US Patent 4,883,666, 1989 | 374 | 1989 |
| Controlled release of dopamine from a polymeric brain implant: in vivo characterization MJ During, A Freese, BA Sabel, WM Saltzman, A Deutch, RH Roth, ... Annals of Neurology: Official Journal of the American Neurological …, 1989 | 284 | 1989 |
| Does visual restitution training change absolute homonymous visual field defects? A fundus controlled study J Reinhard, A Schreiber, U Schiefer, E Kasten, BA Sabel, S Kenkel, ... British Journal of Ophthalmology 89 (1), 30-35, 2005 | 278 | 2005 |
| Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of iv dalargin injections U Schröder, BA Sabel Brain research 710 (1-2), 121-124, 1996 | 217 | 1996 |
| Vision restoration after brain and retina damage: the “residual vision activation theory” BA Sabel, P Henrich-Noack, A Fedorov, C Gall Progress in brain research 192, 199-262, 2011 | 212 | 2011 |
| Mental stress as consequence and cause of vision loss: the dawn of psychosomatic ophthalmology for preventive and personalized medicine BA Sabel, J Wang, L Cárdenas-Morales, M Faiq, C Heim EPMA journal 9 (2), 133-160, 2018 | 210 | 2018 |
| Efficacy of oral dalargin-loaded nanoparticle delivery across the blood–brain barrier U Schroeder, P Sommerfeld, BA Sabel Peptides 19 (4), 777-780, 1998 | 198 | 1998 |
| GM1 ganglioside treatment facilitates behavioral recovery from bilateral brain damage BA Sabel, MD Slavin, DG Stein Science 225 (4659), 340-342, 1984 | 187 | 1984 |
| Visual field enlargement after computer training in brain-damaged patients with homonymous deficits: an open pilot trial E Kasten, BA Sabel Restorative neurology and neuroscience 8 (3), 113-127, 1995 | 180 | 1995 |
| Dynamic reorganization of brain functional networks during cognition M Bola, BA Sabel Neuroimage 114, 398-413, 2015 | 169 | 2015 |
| Attentional cueing improves vision restoration therapy in patients with visual field defects DA Poggel, E Kasten, BA Sabel Neurology 63 (11), 2069-2076, 2004 | 156 | 2004 |
| Restoration of vision by training of residual functions BA Sabel, E Kasten Current opinion in ophthalmology 11 (6), 430-436, 2000 | 154 | 2000 |
| Vision restoration therapy (VRT) efficacy as assessed by comparative perimetric analysis and subjective questionnaires BA Sabel, S Kenkel, E Kasten Restorative Neurology and Neuroscience 22 (6), 399-420, 2004 | 153 | 2004 |
| Apoptotic versus necrotic characteristics of retinal ganglion cell death after partial optic nerve injury A BIEN, CI SEIDENBECHER, TM BÖCKERS, BA SABEL, MR KREUTZ Journal of neurotrauma 16 (2), 153-163, 1999 | 148 | 1999 |
| Surfactants, not size or zeta-potential influence blood–brain barrier passage of polymeric nanoparticles N Voigt, P Henrich-Noack, S Kockentiedt, W Hintz, J Tomas, BA Sabel European Journal of pharmaceutics and Biopharmaceutics 87 (1), 19-29, 2014 | 146 | 2014 |
| Vision-related quality of life in first stroke patients with homonymous visual field defects C Gall, GH Franke, BA Sabel Health and quality of life outcomes 8, 1-14, 2010 | 146 | 2010 |
| Non-invasive alternating current stimulation improves vision in optic neuropathy BA Sabel, AB Fedorov, N Naue, A Borrmann, C Herrmann, C Gall Restorative neurology and neuroscience 29 (6), 493-505, 2011 | 138 | 2011 |
